NCT06379386View on ClinicalTrials.gov

Long-term Prognosis and Valve Durability of TAVR

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions
Aortic Valve Stenosis and Insufficiency
Interventions
PROCEDURE

Transcatheter aortic valve replacement

A total of 1000 consecutive patients with aortic valve disease undergoing TAVR will be enrolled. Clinical follow-up will be conducted in the periprocedural and after TAVR at 1 month, 5 years, and 10 years

Trial Locations (1)

710032

RECRUITING

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER